176 related articles for article (PubMed ID: 8198985)
1. Phosphorus-31 metabolism of post-menopausal breast cancer studied in vivo by magnetic resonance spectroscopy.
Twelves CJ; Porter DA; Lowry M; Dobbs NA; Graves PE; Smith MA; Rubens RD; Richards MA
Br J Cancer; 1994 Jun; 69(6):1151-6. PubMed ID: 8198985
[TBL] [Abstract][Full Text] [Related]
2. Phosphorus-31 metabolism of human breast--an in vivo magnetic resonance spectroscopic study at 1.5 Tesla.
Twelves CJ; Lowry M; Porter DA; Dobbs NA; Graves PE; Smith MA; Richards MA
Br J Radiol; 1994 Jan; 67(793):36-45. PubMed ID: 8298873
[TBL] [Abstract][Full Text] [Related]
3. Effect of estrogen withdrawal on energy-rich phosphates and prediction of estrogen dependence monitored by in vivo 31P magnetic resonance spectroscopy of four human breast cancer xenografts.
Kristensen CA; Kristjansen PE; Brünner N; Clarke R; Spang-Thomsen M; Quistorff B
Cancer Res; 1995 Apr; 55(8):1664-9. PubMed ID: 7712472
[TBL] [Abstract][Full Text] [Related]
4. Unique aspects of human newborn cerebral metabolism evaluated with phosphorus nuclear magnetic resonance spectroscopy.
Younkin DP; Delivoria-Papadopoulos M; Leonard JC; Subramanian VH; Eleff S; Leigh JS; Chance B
Ann Neurol; 1984 Nov; 16(5):581-6. PubMed ID: 6508240
[TBL] [Abstract][Full Text] [Related]
5. [Changes of 3-tesla 31P-MR spectroscopy of bone and soft tissue tumors].
Qi ZH; Li CF; Ma XX; Li ZF; Zhang K; Yu DX
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):442-6. PubMed ID: 19950555
[TBL] [Abstract][Full Text] [Related]
6. Phosphomonoester is associated with proliferation in human breast cancer: a 31P MRS study.
Kalra R; Wade KE; Hands L; Styles P; Camplejohn R; Greenall M; Adams GE; Harris AL; Radda GK
Br J Cancer; 1993 May; 67(5):1145-53. PubMed ID: 8494715
[TBL] [Abstract][Full Text] [Related]
7. 31P NMR study of cisplatin- and doxorubicin-induced changes in tumour metabolism in rats with a cisplatin-sensitive or -resistant immunocytoma.
Sijens PE; van Echteld CJ; van Rijssel RH; Lagendijk JJ; Neijt JP; de Jong WH; van der Minnen AC; de Groot G; Seijkens D
NMR Biomed; 1990 Jun; 3(3):124-31. PubMed ID: 2386659
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro studies of cyclophosphamide chemotherapy in a mouse mammary carcinoma by 31P NMR spectroscopy.
Street JC; Mahmood U; Matei C; Koutcher JA
NMR Biomed; 1995 Jun; 8(4):149-58. PubMed ID: 8771089
[TBL] [Abstract][Full Text] [Related]
9. Quantitative in vivo 31P magnetic resonance spectroscopy of Alzheimer disease.
Gonzalez RG; Guimaraes AR; Moore GJ; Crawley A; Cupples LA; Growdon JH
Alzheimer Dis Assoc Disord; 1996; 10(1):46-52. PubMed ID: 8919496
[TBL] [Abstract][Full Text] [Related]
10. Use of phosphorus-31 MR spectroscopy to monitor response to chemotherapy in non-Hodgkin lymphoma.
Bryant DJ; Bydder GM; Case HA; Collins AG; Cox IJ; Makepeace A; Pennock JM
J Comput Assist Tomogr; 1988; 12(5):770-4. PubMed ID: 3170838
[TBL] [Abstract][Full Text] [Related]
11. Non-alcoholic fatty liver disease: spectral patterns observed from an in vivo phosphorus magnetic resonance spectroscopy study.
Abrigo JM; Shen J; Wong VW; Yeung DK; Wong GL; Chim AM; Chan AW; Choi PC; Chan FK; Chan HL; Chu WC
J Hepatol; 2014 Apr; 60(4):809-15. PubMed ID: 24291241
[TBL] [Abstract][Full Text] [Related]
12. 31P-magnetic resonance spectroscopy (31P-MRS) of human allografts after renal transplantation.
Klemm A; Rzanny R; Fünfstück R; Werner W; Schubert J; Kaiser WA; Stein G
Nephrol Dial Transplant; 1998 Dec; 13(12):3147-52. PubMed ID: 9870480
[TBL] [Abstract][Full Text] [Related]
13. Human in-vivo 31P MR spectroscopy of benign and malignant breast tumors.
Park JM; Park JH
Korean J Radiol; 2001; 2(2):80-6. PubMed ID: 11752975
[TBL] [Abstract][Full Text] [Related]
14. Clinical magnetic resonance spectroscopy of human breast disease.
Merchant TE; Thelissen GR; de Graaf PW; Den Otter W; Glonek T
Invest Radiol; 1991 Dec; 26(12):1053-9. PubMed ID: 1765437
[TBL] [Abstract][Full Text] [Related]
15. Volume localized in vivo proton MR spectroscopy of breast carcinoma: variation of water-fat ratio in patients receiving chemotherapy.
Jagannathan NR; Singh M; Govindaraju V; Raghunathan P; Coshic O; Julka PK; Rath GK
NMR Biomed; 1998 Nov; 11(8):414-22. PubMed ID: 10221584
[TBL] [Abstract][Full Text] [Related]
16. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances.
Menon DK; Sargentoni J; Taylor-Robinson SD; Bell JD; Cox IJ; Bryant DJ; Coutts GA; Rolles K; Burroughs AK; Morgan MY
Hepatology; 1995 Feb; 21(2):417-27. PubMed ID: 7843715
[TBL] [Abstract][Full Text] [Related]
17. Intracellular pH measurements of the whole head and the basal ganglia in chronic liver disease: a phosphorus-31 MR spectroscopy study.
Patel N; Forton DM; Coutts GA; Thomas HC; Taylor-Robinson SD
Metab Brain Dis; 2000 Sep; 15(3):223-40. PubMed ID: 11206591
[TBL] [Abstract][Full Text] [Related]
18. Visibility of phospholipids in 31P NMR spectra of human breast tumours in vivo.
Lowry M; Porter DA; Twelves CJ; Heasley PE; Smith MA; Richards MA
NMR Biomed; 1992; 5(1):37-42. PubMed ID: 1550708
[TBL] [Abstract][Full Text] [Related]
19. Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer.
Piccart MJ; Di Leo A; Beauduin M; Vindevoghel A; Michel J; Focan C; Tagnon A; Ries F; Gobert P; Finet C; Closon-Dejardin MT; Dufrane JP; Kerger J; Liebens F; Beauvois S; Bartholomeus S; Dolci S; Lobelle JP; Paesmans M; Nogaret JM
J Clin Oncol; 2001 Jun; 19(12):3103-10. PubMed ID: 11408507
[TBL] [Abstract][Full Text] [Related]
20. A study of the relationship of metabolic MR parameters to estrogen dependence in breast cancer xenografts.
Liu T; Nath K; Liu W; Zhou R; Chen IW
NMR Biomed; 2015 Sep; 28(9):1087-96. PubMed ID: 26174437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
